<?xml version="1.0" encoding="UTF-8"?>
<p>This study is a two-armed randomized controlled trial with follow-up at 6â€Šmonths (Fig. 
 <xref ref-type="fig" rid="F1">1</xref>). Data will be collected before the first cycle of chemotherapy (T0), after chemotherapy (T1), and 6 months later (T2). The primary outcome for this study is muscle fiber size. Secondary outcomes are: regulators of muscle fiber size and function, indicators of cellular stress and mitochondrial function, myokines with potential antitumor effects, muscle strength, and cardiorespiratory fitness. All outcomes are listed in Table 
 <xref rid="T1" ref-type="table">1</xref>.
</p>
